Status:
COMPLETED
International COVID-19 Clinical Evaluation Registry -2 (HOPE-2)
Lead Sponsor:
St Carlos Hospital, Madrid, Spain
Conditions:
Covid19
Eligibility:
All Genders
Brief Summary
PURPOSE. The main objective of the present study is to carefully characterize the clinical profile of individuals with lasting sequelae after a COVID-19 admission. As secondary objectives, the analys...
Eligibility Criteria
Inclusion
- Patients discharged (deceased or alive) from any hospital center with a confirmed diagnosis.
Exclusion
- There are no exclusion criteria, except for the patient's explicit refusal to participate.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 10 2022
Estimated Enrollment :
9299 Patients enrolled
Trial Details
Trial ID
NCT04778020
Start Date
March 1 2021
End Date
January 10 2022
Last Update
January 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clinico San Carlos
Madrid, Spain, 28040